Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, Peter; Shen Lim, Wei; Emberson, Jonathan; Mafham, Marion; Bell, Jennifer; Linsell, Louise; Staplin, Natalie; Brightling, Christopher; Ustianowski, Andrew; Elmahi, Einas; Prudon, Benjamin; Green, Christopher; Felton, Timothy; Chadwick, David; Rege, Kanchan; Fegan, Chris; C. Chappell, Lucy; N. Faust, Saul; Jaki, Thomas; Jeffery, Katie; Montgomery, Alan; Rowan, Kathy; Juszczak, Edmund; Kenneth Baillie, J.; Haynes, Richard; Landray, Martin; Collaborative Group, RECOVERY

doi:10.1101/2020.06.22.20137273

Public

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Published in medRxiv • Jun 22, 2020

Authors:

Peter Horby

Wei Shen Lim

Jonathan Emberson

Abstract

ABSTRACT Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage. Corticosteroids may modulate immune-mediated lung injury and reducing progression to respiratory failure and death. Methods The Randomised Evaluation of COVID-19 therapy (RECOVERY) trial is a randomized, ...

Subject

Medicine

Dexamethasone

Confidence interval

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!